JPWO2021049587A1 - - Google Patents
Info
- Publication number
- JPWO2021049587A1 JPWO2021049587A1 JP2021545597A JP2021545597A JPWO2021049587A1 JP WO2021049587 A1 JPWO2021049587 A1 JP WO2021049587A1 JP 2021545597 A JP2021545597 A JP 2021545597A JP 2021545597 A JP2021545597 A JP 2021545597A JP WO2021049587 A1 JPWO2021049587 A1 JP WO2021049587A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019165722 | 2019-09-11 | ||
JP2019165722 | 2019-09-11 | ||
PCT/JP2020/034361 WO2021049587A1 (ja) | 2019-09-11 | 2020-09-10 | 抗体医薬の効果増強用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2021049587A1 true JPWO2021049587A1 (ja) | 2021-03-18 |
JP7088502B2 JP7088502B2 (ja) | 2022-06-21 |
Family
ID=74865712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021545597A Active JP7088502B2 (ja) | 2019-09-11 | 2020-09-10 | 抗体医薬の効果増強用組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220265698A1 (ja) |
EP (1) | EP4029509A4 (ja) |
JP (1) | JP7088502B2 (ja) |
CN (1) | CN114340669A (ja) |
WO (1) | WO2021049587A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022270559A1 (en) * | 2021-06-22 | 2022-12-29 | Sophy Inc. | Beta-glucan for preventing and/or treating fibrosis and related diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502167A (ja) * | 2002-09-04 | 2006-01-19 | バイオポリマー エンジニアリング,インコーポレイテッド | 全グルカン粒子および抗体を用いた癌治療 |
JP2017524737A (ja) * | 2014-07-10 | 2017-08-31 | バイオセラ,インク. | 腫瘍微小環境に影響する抗癌剤と組み合わせたβ−グルカン |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5331482B2 (ja) | 1974-05-18 | 1978-09-02 | ||
JPS5115632A (ja) | 1974-06-22 | 1976-02-07 | Kumiai Chemical Industry Co | Satsuchusatsudanizai |
JPS5480312A (en) | 1977-12-08 | 1979-06-27 | Asahi Glass Co Ltd | Roll for use in production of float glass |
JPS5937029B2 (ja) | 1979-02-26 | 1984-09-07 | 三菱化学株式会社 | 陰極電着塗装法 |
JP2002204687A (ja) * | 2000-11-09 | 2002-07-23 | Onaka Yasushi | β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用 |
JP4000078B2 (ja) | 2003-03-07 | 2007-10-31 | 株式会社アウレオ | 皮膚用保湿剤 |
JP4369258B2 (ja) | 2004-02-05 | 2009-11-18 | 株式会社アウレオ | 免疫賦活剤 |
JP4054697B2 (ja) | 2003-03-07 | 2008-02-27 | 株式会社アウレオ | 便秘改善剤 |
JP4268105B2 (ja) * | 2004-09-09 | 2009-05-27 | 株式会社アウレオ | β−グルカン含有組成物、その製造方法及び該組成物を含む飲食品若しくは皮膚用保湿剤 |
TWI496578B (zh) | 2009-10-08 | 2015-08-21 | Aureo Co Ltd | 流感病毒感染症的治療劑 |
WO2011068226A1 (ja) | 2009-12-03 | 2011-06-09 | 株式会社アウレオ | マクロファージ貪食能活性化組成物および/またはマクロファージにおけるサイトカイン産生促進組成物 |
JP5554221B2 (ja) | 2010-12-13 | 2014-07-23 | 株式会社アウレオ | ウシの乳房炎の予防・治療用組成物及びウシの乳房炎の予防・治療方法 |
JP6380968B2 (ja) | 2013-10-22 | 2018-08-29 | 株式会社アウレオ | 脂肪蓄積抑制剤 |
ES2774448T3 (es) * | 2014-10-03 | 2020-07-21 | Novartis Ag | Terapias de combinación |
EP4046656A1 (en) * | 2014-11-06 | 2022-08-24 | HiberCell, Inc. | Beta-glucan methods and compositions that affect the tumor microenvironment |
EP3400442A4 (en) * | 2016-01-08 | 2019-06-26 | Biothera, Inc. | BETA-GLUCAN IMMUNOTHERAPIES AFFECTING IMMUNE MICROENVIRONMENT |
JP6293187B2 (ja) | 2016-03-22 | 2018-03-14 | 株式会社アウレオ | 造血機能増進用の組成物、及び貧血の予防及び/又は改善用の組成物 |
-
2020
- 2020-09-10 JP JP2021545597A patent/JP7088502B2/ja active Active
- 2020-09-10 EP EP20862447.8A patent/EP4029509A4/en active Pending
- 2020-09-10 CN CN202080061449.2A patent/CN114340669A/zh active Pending
- 2020-09-10 WO PCT/JP2020/034361 patent/WO2021049587A1/ja active Search and Examination
- 2020-09-10 US US17/631,704 patent/US20220265698A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502167A (ja) * | 2002-09-04 | 2006-01-19 | バイオポリマー エンジニアリング,インコーポレイテッド | 全グルカン粒子および抗体を用いた癌治療 |
JP2017524737A (ja) * | 2014-07-10 | 2017-08-31 | バイオセラ,インク. | 腫瘍微小環境に影響する抗癌剤と組み合わせたβ−グルカン |
Non-Patent Citations (3)
Title |
---|
CLARK C. A. ET AL.: "Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer an", CANCER RES., vol. 76(23), JPN6020040464, 1 December 2016 (2016-12-01), pages 6964 - 74, ISSN: 0004676768 * |
山崎 香織, 他6名: "黒酵母の菌体外β-グルカンの経口投与による抗腫よう効果", 日本農芸化学会大会講演要旨集, vol. 2004, JPN6020040468, 5 March 2004 (2004-03-05), pages 165 - 3, ISSN: 0004676770 * |
木村 善行, 他5名: "Colon 26移植マウスにおけるβ−グルカンの抗腫瘍および抗転移作用", 日本癌学会総会記事, vol. 63, JPN6020040467, 2004, pages 456 - 1197, ISSN: 0004676769 * |
Also Published As
Publication number | Publication date |
---|---|
JP7088502B2 (ja) | 2022-06-21 |
EP4029509A1 (en) | 2022-07-20 |
EP4029509A4 (en) | 2023-10-18 |
US20220265698A1 (en) | 2022-08-25 |
CN114340669A (zh) | 2022-04-12 |
WO2021049587A1 (ja) | 2021-03-18 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20210929 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210929 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220105 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220302 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220325 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220325 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220517 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220531 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7088502 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |